Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
MoonLake Immunotherapeutics (MLTX)
- 18.780
- +0.350+1.90%
Close Apr 14 15:59 ET
- 18.790
- +0.010+0.05%
Pre 04:10 ET
1.35BMarket Cap-5.32P/E (TTM)
19.650High18.665Low1.08MVolume18.750Open18.430Prev Close20.55MTurnover3.05%Turnover RatioLossP/E (Static)71.73MShares62.75052wk High4.42P/B666.26MFloat Cap5.95052wk Low--Dividend TTM35.48MShs Float64.980Historical High--Div Yield TTM5.35%Range %4.250Historical Low19.018Avg Price1Lot Size
MoonLake Immunotherapeutics (MLTX) Cash Flow
Quarterly+Annual
YOY
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -68.12%-196.01M | -21.29%-58.79M | -76.23%-44.54M | -95.52%-54.53M | -155.15%-38.14M | -172.54%-116.59M | -292.68%-48.47M | -173.24%-25.28M | -129.38%-27.89M | -65.64%-14.95M |
| Net income from continuing operations | -89.96%-230.32M | -35.83%-63.02M | -95.74%-70.69M | -126.39%-56.05M | -190.23%-40.56M | -175.06%-121.24M | -488.23%-46.4M | -210.82%-36.12M | -100.42%-24.76M | -14.37%-13.98M |
| Operating gains losses | -5,900.00%-58K | -875.00%-31K | -800.00%-18K | -1,738.24%-5K | -1,370.59%-4K | 101.18%1K | 111.68%4K | 91.65%-2K | 97.99%-272 | 97.95%-272 |
| Depreciation and amortization | 88.88%2.62M | 106.32%751K | 112.25%745K | 116.96%742K | 15.24%378K | 274.32%1.39M | 1.07%364K | 10,568.69%351K | 10,298.30%342K | 9,869.60%328K |
| Other non cash items | -349.34%-1.02M | 80.75%-92K | -22.25%283K | -6,775.00%-1.34M | 193.23%124K | -277.34%-227K | -1,610.94%-478K | 4,999.06%364K | 224.52%20K | -236.23%-133K |
| Change In working capital | 625.32%19.88M | 100.15%6K | 158.72%21.43M | 77.65%-1.19M | 87.03%-369K | 39.14%-3.78M | 39.22%-3.9M | 752.84%8.28M | -309.53%-5.32M | -637.07%-2.85M |
| -Change in receivables | -13.38%-2.03M | -94.27%-847K | 16.16%-612K | -132.04%-420K | 66.74%-146K | -112.62%-1.79M | -29.62%-436K | -622.86%-730K | 25.00%-181K | -172.14%-439K |
| -Change in prepaid assets | 104.35%561K | 171.82%3.86M | -81.56%274K | 53.00%-3.84M | 132.77%273K | -103.17%-12.89M | 25.57%-5.37M | 128.58%1.49M | -824.34%-8.18M | -175.48%-833K |
| -Change in payables and accrued expense | 87.85%23.15M | -206.96%-2.63M | 174.35%21.06M | -2.74%3.26M | 225.39%1.46M | 881.21%12.32M | 88.66%2.46M | 1,562.67%7.68M | 2,607.46%3.35M | -210.91%-1.16M |
| -Change in other current assets | -9,683.33%-587K | --0 | --1.11M | --1K | -33,860.00%-1.7M | 90.91%-6K | 98.48%-1K | --0 | --0 | ---5K |
| -Change in other current liabilities | 14.13%-1.22M | 31.58%-377K | -169.13%-401K | 40.38%-189K | 37.19%-255K | -540.99%-1.42M | -428.95%-551K | -276.62%-149K | -703.65%-317K | -945.72%-406K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -68.12%-196.01M | -21.29%-58.79M | -76.23%-44.54M | -95.52%-54.53M | -155.15%-38.14M | -172.54%-116.59M | -292.68%-48.47M | -173.24%-25.28M | -129.38%-27.89M | -65.64%-14.95M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 198.73%202.99M | 79.70%-29.91M | 51.68%88.4M | 200.58%88.25M | 295.27%56.25M | -716.38%-205.6M | -226.07%-147.33M | 133.42%58.28M | -792.19%-87.74M | -246.60%-28.8M |
| Net PPE purchase and sale | 93.27%-35K | --0 | --0 | --0 | 83.49%-35K | -83.10%-520K | 38.03%-176K | ---132K | --0 | ---212K |
| Net investment purchase and sale | 199.00%203.03M | 79.67%-29.91M | 51.34%88.4M | 200.58%88.25M | 296.84%56.28M | -723.60%-205.08M | -225.61%-147.16M | 133.50%58.41M | -792.19%-87.74M | -245.52%-28.59M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 198.73%202.99M | 79.70%-29.91M | 51.68%88.4M | 200.58%88.25M | 295.27%56.25M | -716.38%-205.6M | -226.07%-147.33M | 133.42%58.28M | -792.19%-87.74M | -246.60%-28.8M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 184.53%146M | 47,843.71%72.4M | 162.30%480K | 0 | 43.44%73.12M | -89.30%51.31M | -99.47%151K | 183K | 0 | 50.98M |
| Net issuance payments of debt | --73.02M | --0 | --0 | --0 | --73.02M | --0 | --0 | --0 | --0 | --0 |
| Net common stock issuance | 37.79%72.4M | --72.4M | --0 | --0 | --0 | -89.11%52.54M | --0 | --0 | --0 | --52.54M |
| Proceeds from stock option exercised by employees | 139.67%580K | --0 | 427.47%480K | --0 | --100K | --242K | --151K | --91K | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | 46.60%-1.47M | --0 | --92K | --0 | ---1.56M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 184.53%146M | 47,843.71%72.4M | 162.30%480K | --0 | 43.44%73.12M | -89.30%51.31M | -99.47%151K | --183K | --0 | --50.98M |
| Net cash flow | ||||||||||
| Beginning cash position | -60.01%180.43M | -6.63%350.74M | -10.53%306.68M | -40.76%271.57M | -60.01%180.43M | 1,042.03%451.17M | 18.07%375.66M | -31.69%342.79M | 814.52%458.44M | 1,042.04%451.17M |
| Current changes in cash | 156.48%152.98M | 91.66%-16.31M | 33.60%44.34M | 129.16%33.72M | 1,162.50%91.23M | -165.79%-270.87M | -247.18%-195.65M | 118.07%33.19M | -125.59%-115.63M | -31.98%7.23M |
| Effect of exchange rate changes | 766.41%1.11M | -78.54%91K | 12.31%-285K | 8,282.35%1.39M | -291.30%-88K | 268.42%128K | 562.01%424K | -6,592.21%-325K | 88.24%-17K | 8,698.13%46K |
| End cash Position | 85.40%334.52M | 85.40%334.52M | -6.63%350.74M | -10.53%306.68M | -40.76%271.57M | -60.01%180.43M | -60.01%180.43M | 18.07%375.66M | -31.69%342.79M | 814.52%458.44M |
| Free cash flow | -67.40%-196.04M | -20.85%-58.79M | -75.31%-44.54M | -95.52%-54.53M | -151.81%-38.18M | -171.95%-117.11M | -285.24%-48.65M | -174.66%-25.41M | -129.38%-27.89M | -67.99%-15.16M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm